These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106 [TBL] [Abstract][Full Text] [Related]
11. Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy. Sørensen VB; Rossing P; Tarnow L; Parving H; Nørgaard T; Kastrup J Clin Sci (Lond); 1998 Dec; 95(6):709-17. PubMed ID: 9831696 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity. Baba T; Ishizaki T Drugs; 1992 Apr; 43(4):464-89. PubMed ID: 1377114 [TBL] [Abstract][Full Text] [Related]
14. Update on calcium antagonists and the kidney. Tobe S Curr Opin Nephrol Hypertens; 2003 May; 12(3):309-15. PubMed ID: 12698071 [TBL] [Abstract][Full Text] [Related]
15. The effect of beta-blockade and angiotensin converting enzyme inhibition on kidney function in diabetic nephropathy. Hommel E J Hypertens Suppl; 1989 Sep; 7(7):S49-51. PubMed ID: 2575661 [TBL] [Abstract][Full Text] [Related]
16. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy. Tarnow L; Sato A; Ali S; Rossing P; Nielsen FS; Parving HH Diabetes Care; 1999 Mar; 22(3):491-4. PubMed ID: 10097934 [TBL] [Abstract][Full Text] [Related]
17. A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy. Kopf D; Schmitz H; Beyer J; Frank M; Bockisch A; Lehnert H Diabetes Nutr Metab; 2001 Oct; 14(5):245-52. PubMed ID: 11806464 [TBL] [Abstract][Full Text] [Related]
18. Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention. Baba T; Neugebauer S; Watanabe T Drugs; 1997 Aug; 54(2):197-234. PubMed ID: 9257079 [TBL] [Abstract][Full Text] [Related]
19. Natural history of early diabetic nephropathy: what are the effects of therapeutic intervention? Melbourne Diabetic Nephropathy Study Group. Jerums G; Allen TJ; Gilbert RE; Hammond J; Cooper ME; Campbell DJ; Raffaele J J Diabetes Complications; 1995; 9(4):308-14. PubMed ID: 8573754 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal disease. Palmer AJ; Annemans L; Roze S; Lamotte M; Lapuerta P; Chen R; Gabriel S; Carita P; Rodby RA; de Zeeuw D; Parving HH Diabetes Care; 2004 Aug; 27(8):1897-903. PubMed ID: 15277414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]